TMCnet News
GenMark Diagnostics to Participate in Upcoming Investor ConferencesCARLSBAD, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in two upcoming investor conferences. GenMark’s management team will be participating in one-on-one meetings at the BTIG MedTech, Life Science & Diagnostic Tools Conference in Snowbird, Utah on Thursday, February 28, 2019. Due to the format of this event no webcast will be available. GenMark’s management is also scheduled to present at the Cowen Annual Health Care Conference in Boston, Massachusetts on Wednesday, March 13th, 201 at 10:00 a.m. ET. Interested parties can access the live and archived webcast at ir.genmarkdx.com. About GenMark Diagnostics Investor Relations Contact |